Stupidity mostly godiva. I honestly thought and believed that...

Stupidity mostly godiva. I honestly thought and believed that IMU was completely de-risked at 62 cents a share and settled back comfortably to watch it grow further and for BP to come along and offer upwards of $1.00 per share. This was during the time when we were being told that there was unequivocal evidence that IMU's vaccines were curing cancer, and the next 12 months were going to blow away all previous expectations. The fear of course was if I sold out at 60 cents the sp would continue to increase and I would lose future gains. I wouldn't be the first investor to make that mistake. I prided myself on doing all the research humanly possible to justify sticking with my investment and I was continually reassured by the CEO's and the Chairman's fluffy presentations. Hindsight is a wonderful thing and I should have put in a stop loss at around 50 cents as I have done with previous stocks. I regret that I didn't.

I attended a shareholders presentation in Sydney where Yuman Fong gave a wonderful address espousing the attributes of CF33 and IMU's other vaccines. If you were there you could not help but be impressed. Unfortunately it now appears that IMU is unable to bring these magnificent drugs to commercialisation and this is reflected in the dismal share price. The CEO, the Chairman and the Marketing Department must take responsibility for this. The recent CR fiasco has further dimmed by flagging confidence in the BOD. The CEO constantly told us that her "dance card was full" indicating that BP were lining up to offer an attractive takeover deal. That was obviously far from the truth.

The CEO is now saying that it could take until 2026 to bring this to commercialisation. The company does not have enough funds to see it through until then and unless there is a hugely positive announcement regarding the CF33 trials within the next few months then another CR will have to made. Heaven knows at what price and at what dilution.

What a shame.